Over 580,000 Blood Pressure Medication Bottles Recalled, FDA Reports
A blood pressure medication made by Teva Pharmaceuticals was recalled by the U.S. Food and Drug Administration (FDA) due to elevated levels of a potential carcinogenic impurity.
Certain lots of the antihypertensive drug, amounting to over half a million bottles, tested positive for this impurity, which is a byproduct of the manufacturing process.
- 1 milligram (mg) capsules of prazosin hydrochloride
- 2 mg capsules of prazosin hydrochloride
- 5 mg capsules of prazosin hydrochloride
It is essential to consult your physician before stopping a medication, even if you're concerned that your bottles are affected.
No one wants to trade high blood pressure for a potentially cancer-causing chemical.
Affected bottles can be identified by lot number and expiration date as outlined in the report published by the FDA.
Author's summary: FDA recalls blood pressure medication due to carcinogenic impurity.
More News
- Choose New Jersey President and CEO Mathews to Join PSEG
- Wemby’s Evolution Is Scary: Spurs Phenom Dominates Again, Leaves Heat Defenders Helpless
- 'Love Island's' Huda Mustafa Apologizes After Laughing At Racist Slur Hurled Towards Olandria Carthen
- Bose headphones and earbuds return to all-time lows for Black Friday
- Post-Profit Antitrust | Yale Law Journal
- Why Ryan Rollins loved Draymond Green coming for him after Stephen Curry incident
- Pras Michel Must Forfeit $64 Million After Criminal Convictions in Foreign Influence Case
- Flyers flying under the radar — and deserve a packed house again | NorthPennNow
- Stephen A. Smith Questions Why Chris Grier Got Fired Before Mike McDaniel After Dolphins' Embarrassing Loss
- Bam Adebayo's evolution into 'three-level scorer' starts with Heat's new offense